
Ionis Pharmaceuticals Inc
NASDAQ:IONS

Intrinsic Value
The intrinsic value of one
IONS
stock under the Base Case scenario is
43.87
USD.
Compared to the current market price of 33.51 USD,
Ionis Pharmaceuticals Inc
is
Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Ionis Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Ionis Pharmaceuticals Inc
Balance Sheet Decomposition
Ionis Pharmaceuticals Inc
Current Assets | 2.4B |
Cash & Short-Term Investments | 4B |
Receivables | 39.7m |
Other Current Assets | -1.6B |
Non-Current Assets | 394m |
PP&E | 262.2m |
Other Non-Current Assets | 131.8m |
Free Cash Flow Analysis
Ionis Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Ionis Pharmaceuticals Inc
Revenue
|
717.3m
USD
|
Cost of Revenue
|
-10.5m
USD
|
Gross Profit
|
706.7m
USD
|
Operating Expenses
|
-1.2B
USD
|
Operating Income
|
-472.4m
USD
|
Other Expenses
|
14.4m
USD
|
Net Income
|
-458m
USD
|
IONS Profitability Score
Profitability Due Diligence
Ionis Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Score
Ionis Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
IONS Solvency Score
Solvency Due Diligence
Ionis Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Score
Ionis Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IONS Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
IONS
is 59.07 USD
with a low forecast of 37.37 USD and a high forecast of 81.9 USD.
Dividends
Current shareholder yield for IONS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IONS
stock under the Base Case scenario is
43.87
USD.
Compared to the current market price of 33.51 USD,
Ionis Pharmaceuticals Inc
is
Undervalued by 24%.